about
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugsPositive selection of protective variants for type 2 diabetes from the Neolithic onward: a case study in Central Asia.Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.A marker for Stevens-Johnson syndrome ...: ethnicity matters.Linkage disequilibrium in human populationsMutations in IFT172 cause isolated retinal degeneration and Bardet-Biedl syndrome.CRB1 mutations in inherited retinal dystrophiesGenetic epidemiology of single-nucleotide polymorphisms.A first trial of retrospective collaboration for positional cloning in complex inheritance: assay of the cytokine region on chromosome 5 by the consortium on asthma genetics (COAG).EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.No association between HLA-B and cutaneous reactions to sulphonamides in human immunodeficiency virus-infected patients.HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz.HLA -A, -B, -DR haplotype frequencies in France--implications for recruitment of potential bone marrow donors.Limb Girdle Muscular Dystrophy Type 2A (CAPN3): Mapping Using Allelic AssociationLinkage analysis of the 5q31–33 candidate region for asthma in 240 UK familiesLinkage analysis of markers on chromosome 11q13 with asthma and atopy in a United Kingdom populationHardy-Weinberg quality control
P50
Q28264524-5FE8455A-F407-4C58-A678-F91A14F4F8B7Q33355142-AECF40E7-AAF9-4E1D-B040-2764C0779586Q33677088-B8BBD43B-A8F3-4C31-A651-24EC059152DAQ34485108-9346A856-4A4F-41A6-822A-FBCE8CA252EFQ35022810-B3E70255-9A53-4675-85EF-C5D0ED1A48E2Q35078642-C79965C3-5A7E-4E22-A5C0-E61CEC2C6E62Q35800472-4ED30B19-A60B-4E55-8074-037AAAB8A942Q36783218-2A6DCA0D-DAC9-43E3-A267-E20BD8124601Q37267162-F68E41C0-95F4-4080-99C4-7320D551E138Q44360290-3DC3139D-58AD-41F2-86A3-9D9AE492AF2AQ45394509-2E1FADA1-26A2-4FFE-86B6-4A55BFC03928Q46732848-39D7A71C-3B92-4218-AF83-215CD65D25DCQ48637773-57F0E098-0ACA-45A6-93C6-EEE23B8ACA82Q57398259-327C3205-362B-49CB-87EC-41954C880BBAQ57416744-F7256A6A-BF67-41C5-90E4-24A27623AF43Q73071674-6903D6E6-4CAF-4B02-956E-49126FCFB7ABQ73606975-C3F5D709-3ECD-47A8-826C-5A2B310D9190
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
C Lonjou
@ast
C Lonjou
@en
C Lonjou
@es
C Lonjou
@nl
type
label
C Lonjou
@ast
C Lonjou
@en
C Lonjou
@es
C Lonjou
@nl
prefLabel
C Lonjou
@ast
C Lonjou
@en
C Lonjou
@es
C Lonjou
@nl
P106
P31
P496
0000-0003-1226-6992